BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20652393)

  • 1. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer.
    Waalkes S; Merseburger AS; Kramer MW; Herrmann TR; Wegener G; Rustemeier J; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ
    Cancer Causes Control; 2010 Nov; 21(11):1905-10. PubMed ID: 20652393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
    Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
    Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
    Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
    BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
    Donat SM; Salzhauer EW; Mitra N; Yanke BV; Snyder ME; Russo P
    J Urol; 2006 Jan; 175(1):46-52. PubMed ID: 16406867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of body mass index in Korean patients with renal cell carcinoma.
    Sung HH; Jeon SS; Park SY; Jeong BC; Seo SI; Lee HM; Choi HY
    Cancer Causes Control; 2012 Mar; 23(3):505-11. PubMed ID: 22350955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].
    Waalkes S; Eggers H; Rustemeier J; Wegener G; Jentzmik F; Schrader M; Hofmann R; Kuczyk MA; Schrader AJ;
    Urologe A; 2011 Sep; 50(9):1118-24. PubMed ID: 21720831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Yamasaki T; Kamba T; Kamoto T; Ogawa O
    Urology; 2007 Jul; 70(1):50-4. PubMed ID: 17656207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does male sex influence the prognosis of patients with renal cancer?
    Waalkes S; Rott H; Herrmann TR; Wegener G; Kramer MW; Merseburger AS; Schrader M; Hofmann R; Kuczyk MA; Schrader AJ
    Onkologie; 2011; 34(1-2):24-8. PubMed ID: 21346381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
    Webster WS; Thompson RH; Cheville JC; Lohse CM; Blute ML; Leibovich BC
    Urology; 2007 Nov; 70(5):900-4; discussion 904. PubMed ID: 18068445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer].
    Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
    Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
    Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
    Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
    Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
    Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
    Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
    Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
    Schips L; Lipsky K; Zigeuner R; Gidaro S; Salfellner M; Rehak P; Pummer K; Hubmer G
    J Surg Oncol; 2004 Nov; 88(2):57-61; discussion 61-2. PubMed ID: 15499606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.